1、杨倩 陈晓宇 彭延申 郑青. 抑癌基因RRM1在胃癌发生、发展中的表达及其临床意义. . 胃肠病学,2012;17(10):587-590 2、董显文,王天蓉,郑青#,黄美兰,冉志华. 炎症性肠病患者硫嘌呤甲基转移酶与嘌呤类药物毒副反应的关系. 胃肠病学,2011;16(8):464-468 3、朱殷 郑青,汪铮#,王园园, 萧树东. 肝癌细胞株7721中CD133+和CD133-亚群生物学特性的比较. 胃肠病学,2011;16(5):281-285 4、Qing Zheng, Wanjun Chen, hong Lu, Qinjuan Sun and SD Xiao.. Comparison of the efficacy of triple versus quadruple therapy on eradication of Helicobacter pylori and antibiotic resistance.. Journal of Digestive Diseases.,2010;11(5):313-318 5、Xian-Wen Dong, Qing Zheng*#, Ming-Ming Zhu, Jing-Lu Tong and Zhi-Hua Ran.. Thiopurine S-methyltransferase polymorphisms and thiopurine toxicity in treatment of inflammatory bowel disease.. World J Gastroenterol.,2010;16(25):3187-3195 6、陈婉珺,郑青#. 胃癌干细胞的研究进展 . 中华消化杂志,2009;29(10): 7、朱殷,郑青#. 胃癌和幽门螺杆菌研究进展. 胃肠病学,2009;14(12):705-709 8、郑 青*,戴 军,李晓波,陆 红,萧树东。. 以泮托拉唑为基础的三联和四联疗法根除幽门螺杆菌疗效的比较—一项单中心、随机、开放、平行对照研究。. 胃肠病学,2009;14(1):8-11 9、褚以忞,郑 青#. 幽门螺杆菌感染对胃黏膜基质金属蛋白酶表达的影响及其与胃癌的关系. 胃肠病学,2008;13(12):750-753 10、郑青*,潘嬿,张林,萧树东 . 评估以雷贝拉唑为基础的三联和四联方案根除幽门螺杆菌的疗效 . 胃肠病学,2006;11(11):645-647 11、Zheng Qing*,Zhang Lin,Pan Yan,Xiao Shudong.. Comparison of the efficacy of 1-day high-dose quadruple therapy verus 7-day triple therapy for treatment of Helicobacter pylori infection. . Journal of Digestive Diseases.,2005;6(4):202-205 12、Olfat FO, Zheng Q, Oleastro M, Voland P, Borén T, Karttunen R, Engstrand L, Rad R, Prinz C, Gerhard M.. Correlation of the H. pylori Adherence Factor BabA with duodenal ulcer disease in four European countries. . Immunol Med Microbiol,2005;44(2):151-156 13、Zheng Qing*,Chen Xiaoyu, Shi Yao, Xiao Shudong.. Development of Gastric Adenocarcinoma in Mongolian gerbils after Long-term Infection of Helicobacter pylori. . J.Gastroenterology and Hepatology.,2004;19(10):1192-1198
|